文献速递心脑血管急症儿科与产科急症

院前惊厥性癫痫持续状态:咪达唑仑联合氯胺酮与单用咪达唑仑的比较

Midazolam and Ketamine for Convulsive Status Epilepticus in the Out-of-Hospital Setting.
PubMed 文献 · Ann Emerg Med · 2024-12-13
一句话结论院前活动性惊厥患者,咪达唑仑后加用氯胺酮者到达医院前惊厥停止的比例高于单用咪达唑仑者(倾向匹配后94.4% vs 82.0%)。

该回顾性队列研究纳入2015年8月1日至2024年8月5日由佛罗里达州大型急救医疗服务系统转运至医院的院前活动性惊厥患者,按方案先给予咪达唑仑;自2017年6月起,咪达唑仑后仍持续惊厥者接受氯胺酮。主要比较氯胺酮组与单用咪达唑仑组到达医院前惊厥停止的比例。598例接受2剂咪达唑仑(未后续使用氯胺酮)者中479例(80.1%)惊厥停止,90例咪达唑仑后使用氯胺酮者中85例(94.4%)停止,组间绝对差异14.3%(95%CI 8.6%至20.1%);倾向匹配后单用咪达唑仑组82.0% vs 氯胺酮组94.4%,差异12.4%(95%CI 3.1%至21.7%)。作者结论认为,院前活动性惊厥患者接受氯胺酮者到达医院前惊厥停止的可能性高于单用咪达唑仑者。

要点

  • 院前活动性惊厥患者,咪达唑仑后加用氯胺酮者到达医院前惊厥停止94.4%(85/90),单用2剂咪达唑仑者80.1%(479/598),绝对差异14.3%(95%CI 8.6%至20.1%)。
  • 倾向匹配后,单用咪达唑仑组惊厥停止82.0%,氯胺酮组94.4%,差异12.4%(95%CI 3.1%至21.7%)。
  • 研究方案为患者先接受咪达唑仑;自2017年6月起,咪达唑仑后仍持续惊厥者接受氯胺酮。
  • 该研究为回顾性队列研究,采用倾向评分匹配和多因素logistic回归分析。

适用人群与场景

  • 院前活动性惊厥、由佛罗里达州大型急救医疗服务系统转运至医院的患者,数据来自2015年8月1日至2024年8月5日。

处置流程与药物剂量

  • 按方案患者先接受咪达唑仑治疗惊厥;自2017年6月起,咪达唑仑后仍持续惊厥者接受氯胺酮。

研究设计与关键结果

  • 回顾性队列研究,纳入院前活动性惊厥患者,比较咪达唑仑后加用氯胺酮与单用咪达唑仑(2剂)到达医院前惊厥停止的比例。
  • 598例接受2剂咪达唑仑(未后续使用氯胺酮)者中479例(80.1%)到达医院前惊厥停止,90例咪达唑仑后使用氯胺酮者中85例(94.4%)停止,组间绝对差异14.3%(95%CI 8.6%至20.1%)。
  • 倾向匹配后,单用咪达唑仑组惊厥停止82.0%,氯胺酮组94.4%,差异12.4%(95%CI 3.1%至21.7%)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在该回顾性研究中,院前活动性惊厥患者接受氯胺酮者到达医院前惊厥停止的可能性高于单用咪达唑仑者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: To determine if ketamine, when added to midazolam for the treatment of out-of-hospital seizures, is associated with an increase in the rate of cessation of convulsions prior to hospital arrival.

METHODS: We performed a retrospective cohort study of out-of-hospital patients with an active convulsive seizure being transported to a hospital by a large emergency medical services system in Florida, using data from August 1, 2015 and August 5, 2024. Per protocol, patients received midazolam first for their seizure. Starting in June 2017, a new protocol was developed in which patients who continued to convulse after midazolam received ketamine. We used propensity score matching and multivariable logistic regression to determine if patients who received ketamine were more likely to stop convulsing prior to hospital arrival than those who received midazolam alone.

RESULTS: Overall, 479 (80.1%) of 598 actively convulsing patients who received 2 doses of midazolam (without subsequent ketamine) had resolution of their convulsions prior to hospital arrival compared with 85 (94.4%) of 90 who received ketamine after midazolam, an absolute difference between groups of 14.3% (95% CI 8.6% to 20.1%). After propensity matching, 82.0% of those in the midazolam only group had resolution of convulsions compared to 94.4% in the ketamine group, a difference of 12.4% (95% CI 3.1% to 21.7%).

CONCLUSION: In this retrospective study of out-of-hospital patients with active convulsive seizures, patients who received ketamine were more likely to have stopped convulsing prior to hospital arrival than those who received midazolam alone.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Zitek T, Scheppke KA, Antevy P, et al. Midazolam and Ketamine for Convulsive Status Epilepticus in the Out-of-Hospital Setting. Ann Emerg Med. 2024. PMID: 39674935. doi:10.1016/j.annemergmed.2024.11.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。